Wells Fargo’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.6K Buy
16,919
+4,626
+38% +$8.37K ﹤0.01% 5236
2025
Q1
$25K Sell
12,293
-145
-1% -$294 ﹤0.01% 5181
2024
Q4
$74.4K Buy
12,438
+872
+8% +$5.22K ﹤0.01% 4858
2024
Q3
$113K Buy
11,566
+3,211
+38% +$31.3K ﹤0.01% 4551
2024
Q2
$171K Buy
8,355
+662
+9% +$13.6K ﹤0.01% 4262
2024
Q1
$347K Buy
7,693
+2,829
+58% +$128K ﹤0.01% 3778
2023
Q4
$230K Buy
4,864
+182
+4% +$8.59K ﹤0.01% 4006
2023
Q3
$190K Sell
4,682
-154
-3% -$6.24K ﹤0.01% 4074
2023
Q2
$515K Buy
4,836
+1,860
+63% +$198K ﹤0.01% 3714
2023
Q1
$888K Buy
2,976
+1,880
+172% +$561K ﹤0.01% 3245
2022
Q4
$377K Sell
1,096
-73
-6% -$25.1K ﹤0.01% 3581
2022
Q3
$221K Buy
1,169
+117
+11% +$22.1K ﹤0.01% 3921
2022
Q2
$222K Buy
1,052
+193
+22% +$40.7K ﹤0.01% 3979
2022
Q1
$288K Sell
859
-373
-30% -$125K ﹤0.01% 4486
2021
Q4
$400K Buy
1,232
+619
+101% +$201K ﹤0.01% 4511
2021
Q3
$298K Buy
613
+22
+4% +$10.7K ﹤0.01% 4658
2021
Q2
$275K Sell
591
-195
-25% -$90.7K ﹤0.01% 4609
2021
Q1
$542K Sell
786
-1,148
-59% -$792K ﹤0.01% 4346
2020
Q4
$1.43M Buy
1,934
+1,175
+155% +$869K ﹤0.01% 3699
2020
Q3
$526K Sell
759
-200
-21% -$139K ﹤0.01% 4193
2020
Q2
$813K Buy
959
+447
+87% +$379K ﹤0.01% 3869
2020
Q1
$184K Sell
512
-533
-51% -$192K ﹤0.01% 4570
2019
Q4
$244K Buy
1,045
+350
+50% +$81.7K ﹤0.01% 4687
2019
Q3
$78K Buy
695
+673
+3,059% +$75.5K ﹤0.01% 5165
2019
Q2
$3K Sell
22
-3
-12% -$409 ﹤0.01% 5671
2019
Q1
$4K Buy
25
+6
+32% +$960 ﹤0.01% 5629
2018
Q4
$1K Hold
19
﹤0.01% 5778
2018
Q3
$2K Hold
19
﹤0.01% 5773
2018
Q2
$3K Buy
+19
New +$3K ﹤0.01% 5747